Synapse Medicine

Synapse Medicine is a France-based startup, founded in 2017, that aims to enhance medication success through clinical decision support. The company has developed a cutting-edge technology, boasting an extensive global knowledge base for medication utilizing algorithms to ensure reliable, up-to-date data. Synapse Medicine offers a SaaS platform and UI components for prescribing, dispensing, and managing medications throughout the patient journey. Its partnerships with world-leading hospitals and digital health companies in the United States, Europe, and Japan demonstrate its commitment to revolutionizing medication regimens. Recently, the company secured a €25.00M Series B investment on 01 March 2022 from notable investors like XAnge, BNP Paribas Developpement, Korelya Capital, MACSF, and Mutuelles Impact. With its innovative approach, Synapse Medicine is poised to significantly impact the Health Care, Medical Devices, and Pharmaceutical industries.